Oaklawn Park is among the racetracks supporting a plan announced Thursday that would phase out the use of bleeder medication Furosemide (Lasix) in 2020 and eliminate its use in stakes races at those tracks in 2021.
Oaklawn Park is among the racetracks supporting a plan announced Thursday that would phase out the use of bleeder medication Furosemide (Lasix) in 2020 and eliminate its use in stakes races at those tracks in 2021.